{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:17:02Z","timestamp":1784290622925,"version":"3.55.0"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MDER"],"DOI":"10.2147\/mder.s16360","type":"journal-article","created":{"date-parts":[[2011,9,19]],"date-time":"2011-09-19T23:24:57Z","timestamp":1316474697000},"page":"179","source":"Crossref","is-referenced-by-count":46,"title":["Tobramycin administered by the TOBI® Podhaler® for persons with cystic fibrosis: a review"],"prefix":"10.2147","author":[{"given":"Dutch","family":"VanDevanter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Geller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2011,9]]},"container-title":["Medical Devices: Evidence and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=11017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T18:15:30Z","timestamp":1477851330000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/tobramycin-administered-by-the-tobireg-podhalerreg-for-persons-with-cy-peer-reviewed-article-MDER"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/mder.s16360","relation":{},"ISSN":["1179-1470"],"issn-type":[{"value":"1179-1470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}